DE102004021739B4 - Metal implant with surface coating - Google Patents

Metal implant with surface coating Download PDF

Info

Publication number
DE102004021739B4
DE102004021739B4 DE200410021739 DE102004021739A DE102004021739B4 DE 102004021739 B4 DE102004021739 B4 DE 102004021739B4 DE 200410021739 DE200410021739 DE 200410021739 DE 102004021739 A DE102004021739 A DE 102004021739A DE 102004021739 B4 DE102004021739 B4 DE 102004021739B4
Authority
DE
Germany
Prior art keywords
metal implant
selenium
layer
metal
implant according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE200410021739
Other languages
German (de)
Other versions
DE102004021739A1 (en
Inventor
Günter Prof. Dr. Marx
Joachim Schreckenbach
Alexandra Voigt
Hans-Ludwig Prof. Dr. Med. Dent. Graf
Volkhard-Hagen Clostermann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GRAF, HANS-LUDWIG, PROF. DR., 04451 BORSDORF, DE
Original Assignee
Heraeus Kulzer GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heraeus Kulzer GmbH filed Critical Heraeus Kulzer GmbH
Priority to DE200410021739 priority Critical patent/DE102004021739B4/en
Publication of DE102004021739A1 publication Critical patent/DE102004021739A1/en
Application granted granted Critical
Publication of DE102004021739B4 publication Critical patent/DE102004021739B4/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/04—Metals or alloys
    • A61L27/06—Titanium or titanium alloys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/30—Inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/30—Inorganic materials
    • A61L27/32—Phosphorus-containing materials, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2/3094—Designing or manufacturing processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005—The prosthesis being constructed from a particular material
    • A61F2310/00011—Metals or alloys
    • A61F2310/00023—Titanium or titanium-based alloys, e.g. Ti-Ni alloys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00389—The prosthesis being coated or covered with a particular material
    • A61F2310/00592—Coating or prosthesis-covering structure made of ceramics or of ceramic-like compounds
    • A61F2310/00796—Coating or prosthesis-covering structure made of a phosphorus-containing compound, e.g. hydroxy(l)apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents

Abstract

Medizinisches Metallimplantat mit biokompatibler, poröser Oberflächenschicht, dadurch gekennzeichnet, dass die Schicht durch elektrochemisch-plasmachemische anodische Oxidation erhalten wird und Selen enthält.medical Metal implant with biocompatible, porous surface layer, characterized that the layer by electrochemical-plasmachemic anodic Oxidation is obtained and contains selenium.

Description

Die Erfindung betrifft oberflächenbeschichtete medizinische Metallimplantate, besonders aus Titan oder Titanbasislegierungen, geeignet für die Implantation in Knochen, sowie die Herstellung der beschichteten Metallimplantate.The The invention relates to surface-coated medical metal implants, in particular of titanium or titanium-based alloys, suitable for the implantation in bone, as well as the production of the coated ones Metal implants.

Selen besitzt im menschlichen Organismus eine essentielle Rolle für das Immunsystem. Es liegt dabei in einer Vielzahl von Proteinen vor. Das Spurenelement ist unter anderem Bestandteil des antioxidativ wirkenden Enzyms Glutathionperoxidase, welches den Schutzmechanismus gegen freie Radikale durch das Selen aktiviert. Auch die Aktivität eines Schilddrüsenhormones ist durch gezielte Selenaufnahme beeinflussbar. Das Element ist hierbei im Selenocystein gebunden.selenium has an essential role for the immune system in the human organism. It is present in a variety of proteins. The trace element is part of the antioxidant enzyme Glutathione peroxidase, which is the protective mechanism against free Radicals activated by the selenium. Also the activity of a thyroid Hormones is influenced by specific selenium intake. The element is bound in selenocysteine.

Neben der Stärkung des Immunsystems besitzt Selen eine entzündungshemmende Wirkung. Entsprechende Anwendungen werden in der Krebstherapie beschrieben und zur Heilung genutzt. Die tägliche Selenaufnahmedosis sollte zwischen 70 und 400 μg/Tag liegen, da sonst Mangelerscheinungen oder Selenosen folgen.Next the strengthening In the immune system selenium has an anti-inflammatory effect. Appropriate Applications are described in cancer therapy and for healing used. The daily Selenaufnahmedosis should be between 70 and 400 micrograms / day, otherwise deficiency symptoms or Selenoses follow.

Die antiseptische bzw. entzündungshemmende Wirkung von Selenverbindungen wird als „anti-fouling agent" in WO 00/016624 A1 bei medizinischen Implantanten beschrieben. Dabei wird die Selenverbindung aber erst kurz vor der Anwendung durch Tränken aufgebracht. Ein weiterer Einsatz selenhaltiger Implantatmaterialien für subkutane Implantate auf der Basis von Gläsern geschmolzener Natriumoxid-Kaliumoxid-Zinkoxid-Selenoxid-Mischungen findet sich in AU 556909 B2 . Es finden sich im Stand der Technik jedoch keine Hinweise auf poröse, biokompatible Oberflächenschichten, welche gezielt Se-Anteile aufwiesen.The antiseptic or anti-inflammatory action of selenium compounds is described as an "anti-fouling agent" in medical implants in WO 00/016624 A1, but the selenium compound is applied only shortly before application by impregnation the base of glasses of molten sodium oxide-potassium oxide-zinc oxide-selenium oxide mixtures can be found in AU 556909 B2 , However, there are no indications in the prior art of porous, biocompatible surface layers which have specific Se contents.

Nach WO 02/078759 A1 können poröse Oberflächenschichten auf Ti-Implantaten mittels Ethylendiamintetraessigsäure-haltigen Elektrolyten erhalten werden.To WO 02/078759 A1 can porous surface layers on Ti implants using ethylenediaminetetraacetic acid-containing Electrolytes are obtained.

In WO 00/72776 A1 werden poröse Oxidschichtstrukturen auf Ti-Implantaten diskutiert, die keine Selen-Komponenten enthalten, aber auch keine die Biokompatibilität steigernden Verbindungen wie beispielsweise Ca-Phosphate aufweisen, wie sie in US-Patent 6,596,338 B2 aufgeführt werden.In WO 00/72776 A1 become porous Oxide layer structures discussed on Ti implants that do not contain selenium components but also biocompatibility-enhancing compounds such as For example, have Ca phosphates, as described in US Patent 6,596,338 B2 listed become.

Der vorliegenden Erfindung lag die Aufgabe zugrunde, Oberflächen von Metallimplantaten derart zu beschichten bzw. zu modifizieren, dass biokompatible poröse Oberflächen mit biologisch wirksamen Selenkomponenten entstehen und eine Verbesserung der antiseptischen bzw. entzündungshemmenden Wirkung der Metallimplantate erreicht wird.Of the Present invention was based on the object surfaces of To coat or modify metal implants such that biocompatible porous surfaces with biologically active selenium components and an improvement the antiseptic or anti-inflammatory Effect of metal implants is achieved.

Erfindungsgemäß wird auf das Metallimplantatmaterial eine poröse selenhaltige Schicht aus bio-kompatiblem Material mit Hilfe elektrochemisch-plasmachemische Oxidation aufgebracht. Die erfindungsgemäße Schicht enthält im allgemeinen bis zu 1,1% Se. Das Selen wird in die Schichtmatrix eingelagert. Bevorzugt werden als biokompatible Schichten poröse, Ca-phosphathaltige Schichten eingesetzt,
d.h. es werden Ca-phosphathaltige Schichten mittels plasmachemisch-elektrochemischer anodischer Oxidation von Titanimplantaten in selenhaltigen Elektrolytsystemen erzeugt. Dabei ist der Konzentrationsbereich der darin enthaltenen Selenverbindungen so zu wählen, dass keine verstärkte Selenabscheidung auf der Kathodenoberfläche auftritt, sondern eine Einlagerung des Selens in die Schicht erfolgt.According to the invention, a porous selenium-containing layer of bio-compatible material is applied to the metal implant material with the aid of electrochemical-plasmachemical oxidation. The layer of the invention generally contains up to 1.1% Se. The selenium is incorporated in the layer matrix. Preference is given to using porous, calcium phosphate-containing layers as biocompatible layers,
ie Ca-phosphate-containing layers are produced by means of plasma-chemical-electrochemical anodic oxidation of titanium implants in selenium-containing electrolyte systems. In this case, the concentration range of the selenium compounds contained therein should be chosen so that no increased selenium deposition on the cathode surface occurs, but a storage of selenium in the layer takes place.

Die so gebildete selenhaltige Schicht ist porös und zeigt eine stark strukturierte Oberfläche. Die auf dem Ti-Substrat fest haftende Schicht verfügt über ein Porensystem, welches nicht untereinander vernetzt ist, sondern aus isolierten geschlossenen bzw. zur Oberfläche geöffneten Poren mit einem mittlerem Porendurchmesser von 1–2 μm besteht.The thus formed selenium-containing layer is porous and shows a highly structured Surface. The firmly adhering to the Ti substrate layer has a Pore system, which is not networked with each other, but out isolated closed or open to the surface pores with a middle Pore diameter of 1-2 microns.

Neben dem Einsatz von Kalziumdihydrogenphospat-Grundelektrolyten, können auch Schwefel- oder Phosphorsäurelösungen als Grundelektrolyt dienen. Die selenhaltige Verbindung wird im Grundelektrolyten gelöst und das Metallimplantat darin bei hohen Spannungen einer elektrochemisch-plasmachemischen Oxidation unterworfen.Next The use of calcium dihydrogen phosphate base electrolytes may also Sulfuric or phosphoric acid solutions as Serve basic electrolyte. The selenium-containing compound is in the base electrolyte solved and the metal implant therein at high voltages of an electrochemical-plasma-chemical Subjected to oxidation.

Der Selenanteil bewirkt eine langsame Freisetzung des Selens. Die mikrobizide Wirkung macht erfindungsgemäß beschichtete Metallimplantate insbesondere für Risikopatientengruppen geeignet.Of the Selenium causes a slow release of selenium. The microbicides Effect makes coated according to the invention Metal implants in particular for Risk patient groups suitable.

Die Erfindung wird an nachstehendem Ausführungsbeispiel beschrieben.The Invention will be described in the following embodiment.

Beispiel:Example:

30 g/l Kalziumdihydrogenphospat und 0,8 g/l Natriumselenat werden in wässriger Lösung aufgelöst. In diesem Elektrolyten wird die elektrochemisch-plasmachemische Oxidation eines Ti-Dental-implantates mit einer Gesamtoberfläche von 2,5 cm2 bei Elektrolyttemperaturen zwischen 18°C–35°C so durchgeführt, dass 130 s an der Metallimplantatoberfläche Plasmaentladungen auftreten. Das Anodenpotential liegt dabei im Bereich von 165 V.30 g / l calcium dihydrogen phosphate and 0.8 g / l sodium selenate are dissolved in aqueous solution. In this electrolyte, the electrochemical-plasmachemic oxidation of a Ti-dental implant with a total surface area of 2.5 cm 2 at electrolyte temperatures between 18 ° C-35 ° C is performed so that 130 s on the metal implant surface plasma discharges occur. The anode potential is in the range of 165 V.

Anschließend erfolgt die Spülung des Metallimplantates in dest. Wasser. Die Abschlußspülung erfolgt in einem Wasser/Propanol Gemisch 1:1.Then done the conditioner of the metal implant in dest. Water. The final rinse takes place in a water / propanol mixture 1: 1.

Claims (7)

Medizinisches Metallimplantat mit biokompatibler, poröser Oberflächenschicht, dadurch gekennzeichnet, dass die Schicht durch elektrochemisch-plasmachemische anodische Oxidation erhalten wird und Selen enthält.Medical metal implant with biocompatible, porous surface layer, characterized in that the layer is obtained by electrochemical-plasmachemic anodic oxidation and contains selenium. Metallimplantat nach Anspruch 1, dadurch gekennzeichnet, dass das Metallimplantat aus Titan oder dessen Legierungen ist.Metal implant according to claim 1, characterized in that the metal implant is made of titanium or its alloys. Metallimplantat nach Anspruch 1 oder 2, gekennzeichnet dadurch, dass die Schicht Calciumphosphat enthält.Metal implant according to claim 1 or 2, characterized in that the layer contains calcium phosphate. Metallimplantat nach einem der vorstehenden Ansprüche, gekennzeichnet dadurch, dass die Oberflächenschicht 0,01–1,1% Selen enthält.Metal implant according to one of the preceding claims in that the surface layer 0.01 to 1.1% Contains selenium. Verfahren zur Herstellung eines Metallimplantats nach einem der vorstehenden Ansprüche 1 bis 4, dadurch gekennzeichnet, dass man ein medizinisches Metallimplantat nach Anspruch 1 – in einem selenhaltigen Calciumdihydrogenphospat-Grundelektrolyten – elektrochemisch-plasmachemisch anodisch oxidiert.Method for producing a metal implant according to one of the preceding claims 1 to 4, characterized that a medical metal implant according to claim 1 - in one selenium-containing calcium dihydrogen phosphate base electrolyte - electrochemical-plasma-chemical anodized. Verfahren nach Anspruch 5, gekennzeichnet dadurch, dass dem Grundelektrolyten Selen in Form von Alkaliselenaten in Konzentrationen von 0,1–1,5% zugesetzt wird.Method according to claim 5, characterized in that that the base electrolyte contains selenium in the form of alkali metal selenates in Concentrations of 0.1-1.5% added becomes. Verfahren nach Anspruch 5, gekennzeichnet dadurch, dass der Grundelektrolyt schwefel- und/oder phosphorsauer ist.Method according to claim 5, characterized in that that the base electrolyte is sulfur and / or phosphoric acid.
DE200410021739 2004-04-30 2004-04-30 Metal implant with surface coating Expired - Fee Related DE102004021739B4 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE200410021739 DE102004021739B4 (en) 2004-04-30 2004-04-30 Metal implant with surface coating

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE200410021739 DE102004021739B4 (en) 2004-04-30 2004-04-30 Metal implant with surface coating

Publications (2)

Publication Number Publication Date
DE102004021739A1 DE102004021739A1 (en) 2005-11-24
DE102004021739B4 true DE102004021739B4 (en) 2007-11-22

Family

ID=35219988

Family Applications (1)

Application Number Title Priority Date Filing Date
DE200410021739 Expired - Fee Related DE102004021739B4 (en) 2004-04-30 2004-04-30 Metal implant with surface coating

Country Status (1)

Country Link
DE (1) DE102004021739B4 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1991284A4 (en) * 2006-02-01 2012-07-04 Jake Barralet Bioimplants for use in tissue growth
DE102006025682A1 (en) 2006-06-01 2007-12-06 Linde Ag Production of a medical implant for joints comprises coating the implant with a particulate material by cold gas spraying
EP2097118B1 (en) * 2006-12-21 2013-09-18 Thommen Medical Ag Bioactive implant coating
DE102007032686A1 (en) * 2007-07-13 2009-01-15 Biotronik Vi Patent Ag Stent with a coating
DE102007042451A1 (en) * 2007-09-06 2009-03-12 Biotronik Vi Patent Ag Stent with a body made of a biocorrodible alloy
DE102009016554A1 (en) 2009-02-19 2010-09-09 Heraeus Kulzer Gmbh Medical implant i.e. dental implant, for implanting in human body, has metallic body comprising surface layer which contains calcium and/or phosphorus, where zirconium and/or zirconium dioxide are stored in surface layer
ES2399261B1 (en) * 2011-09-13 2013-10-18 Universidad De Vigo SYNTHETIC COATING OF BONE IMPLANT.

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0987031A1 (en) * 1998-09-15 2000-03-22 Isotis B.V. Method for coating medical implants
DE10227935A1 (en) * 2002-06-21 2004-01-15 Heraeus Kulzer Gmbh & Co. Kg Antibiotic coating of porous bodies and process for their production and use
EP1407764A1 (en) * 1998-04-17 2004-04-14 PSIMEDICA Limited Implants for administering substances and methods of producing implants

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1407764A1 (en) * 1998-04-17 2004-04-14 PSIMEDICA Limited Implants for administering substances and methods of producing implants
EP1071398B1 (en) * 1998-04-17 2004-05-26 PSIMEDICA Limited Implants for administering substances and methods of producing implants
EP0987031A1 (en) * 1998-09-15 2000-03-22 Isotis B.V. Method for coating medical implants
DE10227935A1 (en) * 2002-06-21 2004-01-15 Heraeus Kulzer Gmbh & Co. Kg Antibiotic coating of porous bodies and process for their production and use

Also Published As

Publication number Publication date
DE102004021739A1 (en) 2005-11-24

Similar Documents

Publication Publication Date Title
EP1982007B1 (en) Process for producing a metal body and metal bodies
EP1434607A1 (en) Osteophilic implants
DE102008043970A1 (en) A method for producing a corrosion-inhibiting coating on an implant of a biocorrodible magnesium alloy and implant produced by the method
CH695985A5 (en) Surface-modified implants.
EP1166804A2 (en) Bone-like coating for metallic implant materials
DE102006060501A1 (en) Forming corrosion-inhibiting anodized coating on bio-corrodible magnesium alloy implant, treats implant in aqueous or alcoholic solution containing specified ion concentration
EP2004248A1 (en) Biodegrading coatings of salt for protecting implants against organic contaminants
WO2000044305A1 (en) Osteophilic implants
DE102004021739B4 (en) Metal implant with surface coating
EP2097118B1 (en) Bioactive implant coating
EP2323705B1 (en) Implant and method for the production thereof and use thereof
DE102012210807A1 (en) Producing bactericidal layer on base body made of titanium/titanium based alloy, comprises forming silver-containing silicon oxide layer on base body by plasma enhanced chemical vapor deposition method under atmospheric pressure conditions
EP2206526A2 (en) Implantat and method for producing the same
DE60301796T2 (en) OSTEO INTEGRATING BORDER AREA FOR IMPLANTABLE PROSTHESIS AND METHOD FOR THE PRODUCTION THEREOF
EP2236163A2 (en) Implant made of biocorrodible metallic material with a silane coating containing nanoparticles and accompanying production method
EP1512773A1 (en) Chitosan-coated metallic device and method of preparation
DE102012210804B4 (en) A method for producing a bactericidal layer on a base made of titanium or a titanium-based alloy
DE112015001890T5 (en) Implant and manufacturing method therefor
EP1891989A1 (en) Process for the obtention of a degradation resistant surface layer on titanium materials
DE102019219355B4 (en) Implants, implant components and processes for their manufacture
EP2300642B1 (en) Electrochemical immersion method in an aqueous electrolyte for producing a biologically degradation stable surface layer on base bodies made of titanium or titanium based alloys
DE19944970C1 (en) Production of titanium (alloy) implant or substrate, e.g. for cell cultivation ex vivo, with biocompatible surface layer involved treatment with calcium salt melt
DE10158302A1 (en) Electrolytic coating of metal implants with bio-active materials containing calcium phosphate, maintains implant cathodic in aqueous calcium phosphate
DE102004022768A1 (en) Medical implants with glass-ceramic-like multi-element surface layer
DE102019207417A1 (en) Method and arrangement for producing an implant

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: GRAF, HANS-LUDWIG, PROF. DR., 04451 BORSDORF, DE

R119 Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee

Effective date: 20111101